NeuroMetrix Provides Strategic Update
June 27, 2019 07:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company addressing chronic health conditions including chronic pain, sleep disorders and...
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
May 21, 2019 13:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., May 21, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,293,159 titled “Measuring the...
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
May 07, 2019 13:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,279,179 titled...
NeuroMetrix Reports Q1 2019 Financial Results
April 25, 2019 07:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended March 31, 2019. The Company develops and...
NeuroMetrix, Inc. Announces Date for First Quarter 2019 Financial Results Conference Call
April 17, 2019 11:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 first quarter financial results before the opening of the market...
NeuroMetrix Reports New Clinical Studies Published on DPNCheck
January 29, 2019 13:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of three new DPNCheck® clinical studies. DPNCheck is a point-of-care test that provides...
NeuroMetrix Reports Q4 and Full Year 2018 Financial Results
January 24, 2019 07:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter and year ended December 31, 2018. The...
NeuroMetrix Reports Publication of Randomized Controlled Trial of Quell Wearable Pain Relief in Chronic Low Back Pain
January 22, 2019 13:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of results from a randomized controlled trial of Quell® in subjects with chronic low back...
Quell Reports Successful CES 2019
January 16, 2019 13:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix (Nasdaq: NURO) today announced a successful CES 2019, the world’s largest and most influential technology event, which took place...
NeuroMetrix, Inc. Announces Fourth Quarter 2018 Financial Results Conference Call
January 15, 2019 14:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) will issue its fourth quarter 2018 financial results on Thursday morning January 24, 2019. A conference call will...